We showed that SCD retains substantial enzymatic activity even in highly hypoxic circumstances—a result that should encourage SCD inhibitor therapeutics in other strong tumors. Along with delaying tumor growth, the inhibitor experienced an unanticipated beneficial effect on tumor vasculature, secondary to its impact on tumor cells. GBM can be a h